O

Otsuka Pharmaceutical

Global pharma maker of Abilify

Associate Director, Biostatistician - Biostatistics

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • Understand the company's products, the competition, and the pharmaceutical industry in general.
  • Demonstrate competent knowledge of the company's work tools, processes, and policies.
  • Maintain current awareness of new drug developments and statistical methodologies in the business.
  • Demonstrate experience leading Phase 1 and early-phase clinical studies, including First-in-Human, dose-escalation, dose-expansion, and proof-of-concept trials.
  • Have strong working knowledge of applicable U.S. regulatory requirements relevant to clinical trial design, analysis, and reporting.
  • Partner effectively with Clinical Development, Clinical Pharmacology, Translational Medicine, Regulatory Affairs, and other key stakeholders.
  • Have experience working within matrixed, multidisciplinary drug development teams.
  • Influence decisions in a matrix environment without direct authority.
  • Support and champion novel statistical approaches that improve decision-making when working with limited or variable early-phase clinical data.
  • Communicate complex statistical concepts and insights clearly to technical and non-technical audiences.
  • Have in-depth knowledge of statistical principles and applications, and SAS and R programming software.
  • Have strong computer skills and demonstrated experience using Microsoft Word, Excel, PowerPoint, and Outlook.
  • Know how and when to apply organizational policy or procedures to a variety of situations.
  • Manage multiple programs and competing priorities.
  • Have a PhD or Master’s degree in Statistics or Biostatistics.
  • Have a minimum of 7 years of pharmaceutical industry experience with a PhD, or 9 years with a Master’s degree.

Responsibilities

  • Provide strategic statistical leadership for early development programs, including First-in-Human, Phase 1, Phase 1b/2a, and proof-of-concept studies.
  • Lead statistical input into study design, protocol development, analysis planning, interpretation, and reporting of early-phase clinical trials.
  • Develop statistical strategies to address development questions related to safety, dose selection, proof-of-concept, and go/no-go decisions.
  • Serve as the lead statistician for one or more assets and represent Biostatistics on cross-functional asset teams.
  • Partner closely with Clinical Development, Clinical Pharmacology, Clinical Management, Regulatory Affairs, Data Management, and Statistical Programming.
  • Drive evidence-based decision-making by integrating safety, efficacy, pharmacokinetic/pharmacodynamic, biomarker, and translational data.
  • Support key development milestones, including proof-of-concept evaluations, dose selection, and development planning.
  • Influence program strategy by assessing development risks and recommending statistically sound approaches to maximize probability of success.
  • Serve as the Biometrics Trial Lead in the project team and provide expertise and input regarding statistical analysis, tables, figures, and listings format, data collection and quality, and the overall timeline.
  • Manage, mentor, and develop biostatisticians, fostering technical excellence.

Desired Qualifications

  • Experience in the central nervous system area is a plus.
  • Experience with early-phase clinical trials, preferably First-in-Human or pharmacokinetic/pharmacodynamic- or biomarker-focused studies, is a plus.

About the Company

Otsuka Pharmaceutical

Global pharma maker of Abilify

Otsuka Pharmaceutical develops and markets medicines and health products worldwide, including prescription drugs and nutraceutical beverages. Its product lineup ranges from pharmaceutical treatments such as Abilify (an antipsychotic) to consumer health drinks like Pocari Sweat, which helps replenish electrolytes. Abilify works as a psychiatric medication used to treat conditions such as schizophrenia and bipolar disorder, while Pocari Sweat is an ion-replacement beverage designed to restore minerals and fluids after activity or heat. The company differentiates itself through a long history dating back to its founding in 1921, a broad, globally scaled portfolio spanning drugs and health beverages, and a focus on health improvements across populations. Its stated goal is to create new products for better health worldwide.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Tokyo, Japan
Founded
1921

Recently Posted Jobs

Explore more opportunities at Otsuka Pharmaceutical

See more jobs